Association Between Dermatoporosis and Fractural Risk
DermatOstéo
1 other identifier
observational
100
1 country
1
Brief Summary
There is a need for new tools to identify patients who may have osteoporosis before a fracture occurs.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Oct 2020
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
June 24, 2019
CompletedFirst Posted
Study publicly available on registry
June 26, 2019
CompletedStudy Start
First participant enrolled
October 1, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 1, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
February 1, 2021
CompletedJuly 19, 2021
November 1, 2020
4 months
June 24, 2019
July 16, 2021
Conditions
Outcome Measures
Primary Outcomes (1)
compare fracture risk between patients with dermatoporosis and those without dermatoporosis
The fracture risk will be calculated using the FRAX score. The presence of dermatoporosis will be assessed by a simple clinical examination of the forearms and defined by the presence of three clinical signs: cutaneous atrophy, Bateman purpura and presence of pseudo-stellar scars.
BASELINE
Interventions
Simple clinical examination with forearm inspection and palpation; * Radiological examination of BMD; * Calculation of the FRAX® score; * Fact sheet on patients with dermatoporosis, proposal of a topical treatment (cosmetic cream) and completion of the questionnaire specific to dermatoporosis
Eligibility Criteria
Major patients who are to perform dual X-ray absorptiometry (DMO) densitometry.
You may qualify if:
- Patient aged between 40 and 90 years old who has to undergo a bone densitometry (BMD) examination by dual X-ray absorptiometry
- Affiliate or beneficiary of a Social Security scheme
- Express consent to participate in the study.
You may not qualify if:
- Patient benefiting from a legal protection measure
- Pregnant or nursing woman.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Hôpital Fondation Adolphe de Rothschild
Paris, 75019, France
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Thomas SENE, MD PhD
Hôpital Fondation Adolphe de Rothschild
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- NETWORK
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
June 24, 2019
First Posted
June 26, 2019
Study Start
October 1, 2020
Primary Completion
February 1, 2021
Study Completion
February 1, 2021
Last Updated
July 19, 2021
Record last verified: 2020-11
Data Sharing
- IPD Sharing
- Will not share